Efficacy of Repeat Isolated Limb Perfusions With Tumor Necrosis Factor α and Melphalan for Multiple In-Transit Metastases in Patients with Prior Isolated Limb Perfusion Failure
Dirk J. Grünhagen(Erasmus MC), Alexander M.M. Eggermont(University Medical Center Utrecht), Albertus N. van Geel, Boudewijn van Etten(University Medical Center Groningen), Johannes H. W. de Wilt(Radboud University Nijmegen), Wilfried J. Graveland(Erasmus MC Cancer Institute), Flávia Brunstein
Cited by 58
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k